The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 12, 1999, Pages 2943-2949

  Price, R N ^a,c   Cassar, C ^a   Brockman, A ^d   Duraisingh, M ^b   Van Vugt, M ^d,e   White, N J ^c,d   Nosten, F ^c,d   Krishna, S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d MAHIDOL UNIVERSITY   (Thailand)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; CHLOROQUINE; HALOFANTRINE; MEFLOQUINE; QUININE;

ARTICLE; CODON; DRUG STRUCTURE; GENETIC POLYMORPHISM; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMODIUM FALCIPARUM; POINT MUTATION; PRIORITY JOURNAL; THAILAND;

EID: 0032804039     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.12.2943     Document Type: Article

References (38)

1. Adagu, I. S., F. Dias, L. Pinheiro, L. Rombo, V. do Rosario, and D. C. Warhurst. 1996. Guinea Bissau: association of chloroquine resistance of Plasmodium falciparum with the Tyr86 allele of the multiple drug resistance gene Pfmdr1. Trans. R. Soc. Trop. Med. Hyg. 90:90-91. (Letter.)
2. Awad el Kariem, F. M., M. A. Miles, and D. C. Warhurst. 1992. Chloroquine-resistant Plasmodium falciparum isolates from The Sudan lack two mutations in the pfmdr1 gene thought to be associated with chloroquine resistance. Trans. R. Soc. Trop. Med. Hyg. 84:587-589.
3. Basco, L. K., P. Eldin de Pecoulas, J. Le Bras, and C. M. Wilson. 1996. Plasmodium falciparum: molecular characterization of multidrug-resistant Cambodian isolates. Exp. Parasitol. 82:97-103.
4. Basco, L. K., and J. Le Bras. 1992. In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 47:521-527.
5. Basco, L. K., J. Le Bras, Z. Rhoades, and C. M. Wilson. 1995. Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa. Mol. Biochem. Parasitol. 74:157-166.
6. Basco, L. K., and P. Ringwald. 1998. Molecular epidemiology of malaria in Yaounde, Cameroon. Analysis of chloroquine resistance and point mutations in the multidrug resistance (pfmdr1) gene of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 59:577-581.
7. Bhattacharya, P. R., S. Biswas, and L. Kabilan. 1997. Alleles of the Plasmodium falciparum Pfmdr1 gene appear not to be associated with chloroquine resistance in India. Trans. R. Soc. Trop. Med. Hyg. 91:454-455.
8. Bland, M., and D. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310.
9. Brockman, A. Unpublished data.
10. Brockman, A., R. E. L. Paul, T. J. C. Anderson, I. Hackford, L. Phaipun, S. Looareesuwan, F. Nosten, and K. P. Day. 1999. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am. J. Trop. Med. Hyg. 60: 14-21.
11. Cowman, A. F., D. Galatis, and J. K. Thompson. 1994. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc. Natl. Acad. Sci. USA 91:1143-1147.
12. Cox Singh, J., B. Singh, A. Alias, and M. S. Abdullah. 1995. Assessment of the association between three pfmdr1 point mutations and chloroquine resistance in vitro of Malaysian Plasmodium falciparum isolates. Trans. R. Soc. Trop. Med. Hyg. 89:436-437.
13. Duraisingh, M. T., J. Curtis, and D. C. Warhurst. 1998. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp. Parasitol. 89:1-8.
14. Duraisingh, M. T., C. J. Drakeley, O. Muller, R. Bailey, G. Snounou, G. A. T. Targett, B. M. Greenwood, and D. C. Warhurst. 1997. Selection for the tyrosine-86 mutation of the pfmdr1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology 114:205-211.
15. Foote, S. J., D. E. Kyle, R. K. Martin, A. M. Oduola, K. P. Forsyth, D. J. Kemp, and A. F. Cowman. 1990. Several alleles of the multidrug resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345:255-258.
16. Foote, S. J., J. K. Thompson, A. F. Cowman, and D. J. Kemp. 1989. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57:921-930.
17. Lim, A. S., D. Galatis, and A. F. Cowman. 1996. Plasmodium falciparum: amplification and overexpression of pfmdr1 is not necessary for increased mefloquine resistance. Exp. Parasitol. 83:295-303.
18. Nosten, F., F. O. ter Kuile, T. Chongsuphajaisiddhi, C. Luxemburger, H. K. Webster, M. Edstein, L. Phaipun, K. L. Thew, and N. J. White. 1991. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 337:1140-1143.
19. Peel, S. A., P. Bright, B. Yount, J. Handy, and R. S. Baric. 1994. A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 51:648-658.
20. Pradines, B., C. Rogier, T. Fusai, A. Tall, J. F. Trape, and J. C. Doury. 1998. In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs. Am. J. Trop. Med. Hyg. 58:354-357.
21. Price, R., and F. Nosten. Unpublished data.
22. Price, R., G. Robinson, A. Brockman, A. Cowman, and S. Krishna. 1997. Assessment of pfmdr1 gene copy number by tendem competitive polymerase chain reaction. Mol. Biochem. Parasitol. 85:161-169.
23. Price, R. N., F. Nosten, C. Luxemburger, Am Kham, A. Brockman, T. Chongsuphajaisiddhi, and N. J. White. 1995. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 89:523-527.
24. Price, R. N., F. Nosten, C. Luxemburger, M. van Vugt, L. Phaipun, T. Chongsuphajaisiddhi, and N. J. White. 1997. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 91:574-577.
25. Reacher, M. 1981. Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine and sulfadoxine. Lancet ii:1066-1068.
26. Ringwald, P., J. Bickii, and L. K. Basco. 1996. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am. J. Trop. Med. Hyg. 55:254-258.
27. Ruetz, S., U. Delling, M. Brault, E. Schurr, and P. Gros. 1996. The pfmdr1 gene of Plasmodium falciparum confers cellular resistance to antimalarial drugs in yeast cells. Proc. Natl. Acad. Sci. USA 93:9942-9947.
28. Su, X. Z., L. A. Kirkman, H. Fujioka, and T. E. Wellems. 1997. Complex polymorphisms in an ∼330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91:593-603.
29. ter Kuile, F. O., G. Dolan, F. Nosten, M. D. Edstein, C. Luxemburger, L. Phaipun, T. Chongsuphajaisiddhi, H. K. Webster, and N. J. White. 1993. Halofantrine versus mefloquine in the treatment of multi-drug resistant falciparum malaria. Lancet 341:1044-1049.
30. ter Kuile, F. O., F. Nosten, M. Thieren, C. Luxemburger, M. D. Edstein, T. Chongsuphajaisiddhi, L. Phaipun, H. K. Webster, and N. J. White. 1992. High dose mefloquine in the treatment of multidrug resistant falciparum malaria. J. Infect. Dis. 166:1393-1400.
31. Viriyakosol, S., N. Siripoon, C. Petcharapirat, P. Petcharapirat, W. Jarra, S. Thaithong, K. N. Brown, and G. Snounou. 1995. Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies. Bull. W. H. O. 73:85-95.
32. von Seidlein, L., M. T. Duraisingh, C. J. Drakeley, R. Bailey, B. M. Greenwood, and M. Pinder. 1997. Polymorphism of the Pfmdr1 gene and chloroquine resistance in Plasmodium falciparum in The Gambia. Trans. R. Soc. Trop. Med. Hyg. 91:450-453.
33. Webster, H. K., E. F. Boudreau, K. Pavanand, K. Yongvanitchit, and L. W. Pang. 1985. Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method. Am. J. Trop. Med. Hyg. 34:228-235.
34. Wellems, T. E., L. J. Panton, I. Y. Gluzman, V. E. do Rosario, R. W. Gwadz, and A. Walker-Jonah. 1990. Chloroquine resistance not linked to mdr-like genes in Plasmodium falciparum cross. Nature 345:253-255.
35. White, N. J. 1992. Antimalarial drug resistance: the pace quickens. J. Antimicrob. Chemother. 30:571-585. (Review.)
36. Wilson, C. M., A. E. Serrano, A. Wasley, M. P. Bogenschutz, A. H. Shankar, and D. F. Wirth. 1989. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 244:1184-1186.
37. Wilson, C. M., S. K. Volkman, S. Thaithong, R. K. Martin, D. E. Kyle, W. K. Milhous, and D. F. Wirth. 1993. Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol. Biol. Parasitol. 57:151-160.
38. Zalis, M. G., L. Pang, M. S. Silveira, W. K. Milhous, and D. F. Wirth. 1998. Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance. Am. J. Trop. Med. Hyg. 58: 630-637.